FOXO1 and hypertriglyceridemia: These studies have found that activation of FoxO1 was observed in lipid deposition in the liver (Kim et al., 2016); activated FoxO1 induced an increase in liver output of very low-density lipoprotein (rich in TG particles) and hypertriglyceridemia (Kim et al., 2011).